ICCC — IMMUCELL CORP /DE/

—
Nasdaq · Health Care · Life Sciences Tools & Services · CIK 811641 ·
Last close
$11.33
Market Cap
$103.01M
52W High
$12.10
52W Low
$4.52
ADV30
12,498
Next earnings
2026-11-12
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 8,039,951 3,555,060 957,770 952,510 47,958,262 7,914,406 15,184,077
Jun 2026 7,186,113 2,437,222 1,934,934 1,834,656 46,629,796 8,860,205 15,255,260
Mar 2026 10,357,295 4,657,444 1,969,316 1,941,607 44,108,374 6,812,637 14,973,334
Dec 2025 7,625,999 2,910,209 -57,956 -2,849,142 42,532,447 3,806,831 15,476,967

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$5,892,060
Investing CF
$-1,660,499
Financing CF
$-1,369,850
CapEx
$-1,677,399
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.08
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-11,427,490
Inventory
$9,078,466
Receivables
$2,903,635
ST Investments
—
EBIT TTM
$1,250,560
Pretax Income TTM
$853,607
Interest Exp TTM
$396,953
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$30,675,528
EBITDA
$7,050,686
Free Cash Flow
$3,082,192
Enterprise Value
$96,407,384
Total Cash
$8,860,205
Total Debt
$12,447,535
Shares Out
9,091,361
Trailing EPS
$0.07
Book Value
$2.99
ROE
2.6%
ROA
6.2%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 27,644,174 1,649,305 -1,040,027 42,532,447 15,476,967 27,055,480 2,475,292
Dec 2024 26,493,169 -1,640,159 -2,156,629 45,100,477 17,582,290 27,518,187 357,903
Dec 2023 17,471,669 -5,748,078 -5,774,598 43,808,102 18,815,025 24,993,077 -4,674,236
Dec 2022 18,567,962 -2,298,943 -2,493,805 44,860,649 14,480,600 30,380,049 -1,543,871

TTM Snapshot

Revenues TTM
$30,675,528
NetIncome TTM
$787,373
OpCashFlow TTM
—
Assets (Latest)
$46,629,796
Forward EPS
$-0.11

Peers — same industry

TickerNameMarket CapLastDaily %
MXCT MAXCYTE, INC. $120.80M $1.17 —
NNNN Anbio Biotechnology $160.20M $3.65 —
IMDX Insight Molecular Diagnostics Inc. $58.25M $1.78 —
IBAC IB Acquisition Corp. $54.33M $10.85 —
ONMD OneMedNet Corp $293.47M $4.95 —

News headlines (Yahoo Finance, 1h cache)

ImmuCell Corp (ICCC) Q3 2026 Earnings Call Highlights: 46% Sales Surge and Return to Profitability
2026-11-13 23:02 · Yahoo
ImmuCell (ICCC) Q3 2026 Earnings Call Transcript
2026-11-13 20:45 · Yahoo
ImmuCell Q3 Earnings Call Highlights
2026-11-13 16:14 · Yahoo
ImmuCell Corporation Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2026
2026-11-12 21:05 · Yahoo
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2026
2026-11-06 21:05 · Yahoo
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
2026-10-12 20:05 · Yahoo
ImmuCell (ICCC) Q2 2026 Earnings Call Transcript
2026-08-20 22:45 · Yahoo
ImmuCell Corp (ICCC) (Q2 2026) Earnings Call Highlights: Record Net Income and Market Share ...
2026-08-14 23:01 · Yahoo
ImmuCell Q2 Earnings Call Highlights
2026-08-14 14:04 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.